State TX
Clinical Trials in Texas
Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Texas
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
NCT06096090 Phase 2
Recruiting
Phase II Clinical Trial of Interleukin-2 in AD
Condition
Alzheimer Disease
Enrollment
40 pts
Location
United States
Sponsor
The Methodist Hospital Researc
NCT06794996 Phase 2
Recruiting
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...
Condition
Proteinuric Kidney Disease
Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05730283 Phase 2
Recruiting
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Condition
Ototoxicity, Drug-Induced
Enrollment
105 pts
Location
United States
Sponsor
Kevin Winthrop
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06349941 Phase 3
Recruiting
Home-based Cardiac Rehabilitation in Heart Failure
Condition
Heart Failure
Enrollment
332 pts
Location
United States
Sponsor
University of Texas Southweste
NCT06424327 N/A
Recruiting
A Registry for People With Lung Cancer
Condition
Lung Cancer
Enrollment
600 pts
Location
United States, Canada
Sponsor
Memorial Sloan Kettering Cance
NCT05853783 N/A
Recruiting
Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™
Condition
Mouth Diseases
Enrollment
180 pts
Location
United States
Sponsor
Proteocyte Diagnostics Inc.
NCT05950282 N/A
Recruiting
Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
Condition
Insulin Resistance
Enrollment
500 pts
Location
United States
Sponsor
Lilli Health
NCT06532942 Phase 1
Recruiting
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Hea...
Condition
Healthy Volunteers
Enrollment
40 pts
Location
United States
Sponsor
Mannkind Corporation
NCT03932786 N/A
Recruiting
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Condition
Retinoblastoma
Enrollment
900 pts
Location
United States, Canada
Sponsor
Vanderbilt-Ingram Cancer Cente
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT06091254 Phase 3
Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Work...
Condition
Follicular Lymphoma (FL)
Enrollment
822 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
NCT06613360 Phase 1
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, ...
Condition
SLE
Enrollment
24 pts
Location
United States, Australia, Bulgaria
Sponsor
Cullinan Therapeutics Inc.
NCT06429280 N/A
Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Condition
Amblyopia
Enrollment
500 pts
Location
United States
Sponsor
Luminopia
NCT07260253 N/A
Recruiting
Remotely-supervised Neuromodulation in PPA
Condition
Primary Progressive Aphasia(PPA)
Enrollment
80 pts
Location
United States
Sponsor
University of Texas at Austin
NCT06395753 Phase 2
Recruiting
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Condition
Prostate Cancer
Enrollment
66 pts
Location
United States, Belgium, France
Sponsor
Debiopharm International SA
NCT06029660 N/A
Recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of...
Condition
Aortic Aneurysm, Abdominal
Enrollment
180 pts
Location
United States, France, Netherlands
Sponsor
Shape Memory Medical, Inc.
NCT06872723 N/A
Recruiting
CPRIT: Patient Adherence to Lung Cancer Screening
Condition
Lung Cancer Screening
Enrollment
340 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06501196 Phase 1
Recruiting
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Highe...
Condition
Leukemia
Enrollment
170 pts
Location
United States
Sponsor
BlossomHill Therapeutics
NCT00539162 N/A
Recruiting
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Ris...
Condition
Ovarian Cancer
Enrollment
8,000 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05561127 Phase 3
Recruiting
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Condition
Bowel; Stricture
Enrollment
171 pts
Location
United States
Sponsor
GIE Medical
NCT06045754 Phase 4
Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Usteki...
Condition
Crohn's Disease
Enrollment
100 pts
Location
United States, Canada
Sponsor
Takeda
NCT04677751 N/A
Recruiting
Clinical and Electrographic Changes in Responsive Neurostimulation System (RNS) ...
Condition
Epilepsy
Enrollment
10 pts
Location
United States
Sponsor
The University of Texas Health
NCT06444880 Phase 2
Recruiting
Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Ex...
Condition
SMARCB1-Deficient Malignancies
Enrollment
40 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center